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The N-terminal 33 aa of the envelope protein ODV-E66 are suffi-
cient to traffic fusion proteins to intranuclear membranes and
the ODV envelope during infection with Autographa californica
nucleopolyhedrovirus. This sequence has two distinct features:
(i) an extremely hydrophobic sequence of 18 aa and (ii) positively
charged amino acids close to the C-terminal end of the hydrophobic
sequence. In the absence of infection, this sequence is sufficient to
promote protein accumulation at the inner nuclear membrane.
Covalent cross-linking results show that the lysines of the motif are
proximal to FP25K andor BVODV-E26 during transit from the
endoplasmic reticulum to the nuclear envelope. We propose that
the 33 aa comprise a signature for sorting proteins to the inner
nuclear membrane (sorting motif) and that, unlike other resident
proteins of the inner nuclear membrane, ODV-E66 and sorting-
motif fusions do not randomly diffuse from their site of insertion
at the endoplasmic reticulum to the nuclear envelope and viral-
induced intranuclear membranes. Rather, during infection, traf-
ficking is mediated by protein–protein interactions.
Baculovirus infection provides an amplified pulse of integralmembrane proteins that use the continuous membranes of
the endoplasmic reticulum (ER), outer nuclear membrane
(ONM), nuclear pore membrane, and inner nuclear membrane
(INM) during their transit to the viral envelope of the occlusion-
derived virus (ODV). In 1997, Hong et al. (1) showed that the
N-terminal region of the envelope protein ODV-E66 (E66) was
sufficient to traffic fusion proteins to intranuclear membranes
and the ODV envelope during infection with Autographa cali-
fornica nucleopolyhedrovirus. This sequence has two distinct
features: (i) an extremely hydrophobic sequence of 18 aa and (ii)
positively charged amino acids close to the C-terminal end of the
hydrophobic sequence. We propose that these characteristics
comprise a signature for sorting proteins to the INM that we now
refer to as an INM-sorting motif (SM).
When ODV envelope proteins are expressed under their
native promoters, they locate so rapidly to viral-induced intranu-
clear microvesicles and the ODV envelope that intermediates in
the trafficking pathway are difficult to discern. When large
quantities of E66 or SM fusions are expressed by using recom-
binant viruses, the proteins are easily detected in the ER, ONM,
and INM, suggesting that the proteins use these continuous
membranes during trafficking. Because other observable viral
phenomena (e.g., microvesicle formation, viral maturation, etc.)
are similar to wild type, it is likely that these viral proteins are
simply more abundant in their normal pathway (1).
In this study we used a series of SM-fusion proteins to study
trafficking of viral proteins from their site of insertion at the ER
to the nuclear envelope. Even in the absence of infection, this
sequence is sufficient to direct proteins to the INM. During
infection, SM-fusion protein trafficking to the nuclear envelope
is facilitated by other viral proteins: FP25K andor BVODV-
E26 (E26).
Materials and Methods
Insect Cell Lines and Virus. Spodoptera frugiperda (Sf9) cells were
cultured as described (2). Nucleopolyhedrovirus-E2 strain was
used at a multiplicity of infection of 20.
In Vitro Glycosylation Assay. Dog pancreatic or infected Sf9 cell
microsomes (33 h after infection), signal-recognition particle,
and wheat germ extract were prepared (3, 4). PCR and in vitro
transcription were used to generate mRNA containing an N-
GlcNAc acceptor sequence (Fig. 1 A, constructs 2 and 4). The
mRNA was translated by using wheat germ extract in the
presence of 40 nM canine signal-recognition particle, [35S]Met
(0.2 Cil; 1 Ci  37 GBq), and microsomal membranes.
Attached ribosomes were removed by using 2 mM puromycin
(26°C for 10 min). After translation, samples were treated with
endoglycosidase H or peptide N-glycosidase as described by
Braunagel et al. (5). Membranes were sedimented through a
sucrose cushion and analyzed by using SDSPAGE.
Sf9 Cell Transfection, Selective Permeabilization, and Confocal Mi-
croscopy. Sf9 cells were transfected by using calcium phosphate
(2). Digitonin permeabilization was performed essentially as
described by Adam et al. (6). Cells were fixed with 3.7%
paraformaldehyde (room temperature, 10 min), washed three
times, and incubated either with digitonin (30 gml: semiper-
meabilization) or as described by Rosas-Acosta et al. (7) (full
permeabilization). Slides were viewed by using a Zeiss Axiovert
135 microscope with a CARV confocal module (Zeiss Micro-
Imaging and Atto Bioscience) and images were collected at
0.75-m intervals. After viewing at least 20 fields, representative
cells were collected by using Zeiss AXIOVISION 3.1. Antibodies
used were ADL67-Drosophila lamin [1:250 (8)], calnexin-CT
(1:500; StressGen Biotechnologies, Victoria, Canada), calreti-
culin (1:1,000; Affinity BioReagents, Golden, CO), and GFP
(1:1,000; Chemicon International).
Immunoprecipitation, SDSPAGE, and Western Blot. Used for each
precipitation were 1.5  106 cells. At the appropriate time, cells
were collected and resuspended in 500 l of lysis buffer (50 mM
Tris, pH 8.0150 mM NaCl0.1% SDS0.5% sodium desoxy-
cholate0.5% Triton X-100). The cell extract was preabsorbed
with 20l of preimmune serum followed by 20l of protein AG
agarose (50% slurry; Sigma) for 1 h at 4°C. The preadsorbed
extract was precipitated by using 10 l of antibody overnight
followed by a 2-h incubation with 20 l of protein AG agarose.
Abbreviations: ER, endoplasmic reticulum; ONM, outer nuclear membrane; INM, inner
nuclear membrane; ODV, occlusion-derived virus; E66, ODV-E66; SM, sorting motif; E26,
BVODV-E26; TM, transmembrane.
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The bound AG agarose was washed three times in lysis buffer
and analyzed by using SDSPAGE and Western blot. Western
blots were performed as described (7). Antibodies used were
FP25K, no. 2804, 1:5,000; T7 (Novagen), 1:5,000; and E26, no.
7554, 1:5,000.
SM-Scanning Constructs. A series of enhanced-GFP fusions were
constructed by using complementary oligonucleotides. Briefly,
oligonucleotides were mixed in equimolar amounts, annealed,
and ligated into the pIE1-3 vector. The clones were sequence-
confirmed, and the corresponding amino acid sequences are
shown in Fig. 3.
Covalent Cross-Linking. In vivo. Sf9 cells were infected with polhSM-
cassette recombinant virus (sequence shown in Fig. 4), and
cells were collected 33 h after infection. Cells were washed,
resuspended in buffer A (25 mM sodium phosphate150 mM
NaCl, pH 7.0) and frozen for 30 min. After thaw, the cell
membrane was disrupted by Dounce homogenization, and
nuclei were pelleted by centrifugation (1,500  g, 3 min),
washed, and resuspended in buffer A. For every reaction, 200
g of protein was resuspended in 100 l of buffer A including
BS3 (2.5 mM; Pierce Biotechnology) and incubated for 30 min
(room temperature). The samples were analyzed directly,
immunoprecipitated (200 g of protein per precipitation), or
purified by using Talon (BD BioSciences) or HisMag (Nova-
gen) beads per manufacturer instructions.
In vitro. In vitro translations of mRNA were performed in the
presence of rabbit reticulocyte lysate (minus Met) RNasin, 8 eq
of infected Sf9 microsomes, and [35S]Met. After translation,
membranes were sedimented through a sucrose cushion and
resuspended in 50 l of buffer A containing BS3. The SM
cassette and cross-linked complex were precipitated by using the
appropriate antibodies, separated by using SDSPAGE, and
either Western blotted and probed with antibodies or visualized
by using Bio-Rad Molecular Imager FX.
Results
E66 and SM Fusions Constitute Type 1 Signal Anchors. The N-
terminal region of E66 constitutes a noncleaved signal anchor
(9). Thus, orientation would determine the molecular mass
passing through the lateral channel of the nuclear pore (Fig. 1B).
Orientation was determined by constructing a clone that con-
tained a consensus acceptor sequence for N-GlcNAc glycosyla-
tion at the N terminus of E66 or the SM fusion (Fig. 1 A,
constructs 2 and 4). The reaction was treated with endoglyco-
sidase H or peptide N-glycosidase, and molecular mass was
determined by using SDSPAGE. The result shows that protein
mass was reduced by treatment with either endoglycosidase H or
peptide N-glycosidase (Fig. 1 A, lanes 1–4). The orientation of
23-GFP was tested in a similar manner (Fig. 1 A, lanes 5–8).
These results were confirmed by using proteinase K digestion
(data not shown). Thus, E66 is a type I signal anchor with the
bulk of the protein exposed at the cytoplasmic face of the ER
(Fig. 1B).
SM-Fusion Proteins Accumulate at the INM. By using transient
expression, two SM-fusion proteins (33-GFP and 23-GFP)
were monitored to determine their localization in the absence
of infection (sequences shown in Fig. 3, group 1). Because
equivalent data were obtained from either protein, results
from both constructs are shown throughout this article. Three
cellular markers were used: (i) the intermediate filament
protein lamin, which resides largely at the nucleoplasmic face
of the INM; (ii) calreticulin, a soluble, luminal protein of
the ER; and (iii) calnexin, an ER integral membrane protein.
The calnexin antibody recognizes the cytoplasmic region of the
protein.
When 33-GFP was transiently expressed in Sf9 cells, it
colocalized with the ER markers calreticulin (Fig. 2B) and
calnexin (Fig. 2C) and formed a nuclear rim in close juxtapo-
sition with the inner nuclear marker, lamin (Fig. 2A). To
determine whether the SM fusion was capable of locating to
the INM, Sf9 cells transiently expressing the SM fusion were
prepared for electron microscopy and probed with antibody to
GFP and gold-conjugated secondary antibody: 23-GFP is
present at the ER, the ONM, and INM (Fig. 2D). These data
indicate that in the absence of viral infection, 23-GFP locates
throughout the ER and nuclear envelope. Thus, the lateral
channels of the nuclear pore do not restrict movement at the
pore membrane.
Semipermeabilization experiments were performed to de-
termine whether the visible nuclear rimming of the SM fusion
represents localization at the ER positioned at the nuclear
periphery or protein at the INM. This technique utilizes
cholesterol compositional differences to selectively permeabil-
ize the plasma membrane vs. intracellular membranes to allow
antibody penetration (6, 10). When the plasma membrane is
permeabilized, leaving the ER and nuclear envelope intact,
antibodies to lamin are not bound (Fig. 2E1). In contrast,
lamin is visible when membranes are fully permeabilized (Fig.
2F1). In semipermeabilized cells, antibodies to GFP display a
pattern similar to calnexin (Fig. 2E2); however, autof luores-
cence of 33-GFP clearly shows a nuclear rim (Fig. 2E2). When
cells are fully permeabilized, antibodies to GFP show the
same pattern as autof luorescence (Fig. 2F). These results show
that nuclear rimming represents protein accumulation at
the INM.
Fig. 1. Orientation of 23-GFP and E66. (A) Construct 1 is the native sequence E66. Construct 2 shows the added N-GlcNAc acceptor sequence (underlined).
Constructs 3 and 4 show an equivalent sequence modification of 23-GFP. Lanes 1–4 show in vitro translation of E66G, and lanes 5–8 show an equivalent
experiment using 23-GFPG. , translation in the presence of microsomal membranes; , paired reaction with the addition of enzyme; *, unmodified protein;
arrow, glycosylated protein. (B) Schematic orientation of protein in the ER, ONM, pore membrane, and INM.








The Lysine(s) of the SM Are Important for Protein Accumulation at the
Nuclear Envelope. Thinking that the cysteine within the hydro-
phobic sequence might be important for sorting, we generated
a site-directed mutation (C3 A) and evaluated the effects of
the mutation on protein sorting: no effects were observed. We
site-directed the aromatic residues within the transmembrane
(TM) (F,Y 3 A) and still observed normal protein localiza-
tion. Finally, we altered the distance from the C terminus of
the TM to the positively charged amino acids, which resulted
in a dramatic and visible change in protein localization. For
reference, the localization of 23-GFP is shown (Fig. 3, group
1). If the spacing was increased to 11 aa, a less intense nuclear
rim was observed, and more protein was detected at the
peripheral ER (Fig. 3, group 2). When the length of the
hydrophobic sequence was increased and the lysines were
deleted (Fig. 3, group 3), the protein was detected at the cell
surface (Fig. 3) and secreted (confirmed by immunopre-
cipitation; data not shown). If spacing to the lysines was
decreased with minimal changes to the hydrophobic sequence,
the fusion protein was dispersed throughout the ER in a
pattern indistinguishable from calreticulin (Fig. 3, group 4).
These data suggest that the spacing from the C-terminal end
of the hydrophobic sequence andor the composition of the
amino acids between them are critical for nuclear envelope
localization.
The Lysines of the SM Are Proximal to the Viral Proteins FP25K andor
E26 During Trafficking to the Nuclear Envelope. The previous ex-
periment suggests that the lysines in the SM are at or near a
functionally important site that influences the trafficking of the
SM fusion. Therefore, the lysines would serve as useful probes
to identify the protein environment of the SM at various points
in the trafficking pathway. To this end, a cassette was designed
containing the following features: (i) the lysines of the SM are
the only ones present within the encoded protein; (ii) it has a
purification tag; and (iii) it has a unique epitope tag for
unambiguous identification (Fig. 4A). Two recombinant viruses
containing this fusion cassette were generated. In both cases, the
SM cassette was inserted into the polyhedrin gene locus: one
under the control of the polyhedrin promoter and the other virus
under the control of the E66 promoter. Both viruses showed
similar results, and the data obtained from the polyhedrin-
expressed cassette are shown.
SM-cassette-infected cell nuclei were isolated and treated with
the soluble amine–amine cross-linking reagent BS3. One pre-
dominant cross-linked product was observed at 32 kDa (Fig.
4B, lanes 1 and 2). The SM cassette and cross-linked complex
were purified by using the (His)6 sequence and resolved by
SDSPAGE. The 32-kDa cross-linked band was subjected to
in-gel trypsin digestion and analyzed by using matrix-assisted
laser desorption ionizationtime of flight MS (11). Two viral
proteins were identified: FP25K and E26 (5% and 8% overall
coverage, respectively). We note that an additional, higher
molecular mass band was detected; however, its identity was not
determined.
Immunoprecipitation was performed to confirm that FP25K
andor E26 cross-linked to the SM cassette. Antibodies to
FP25K or E26 each precipitated the cross-linked protein com-
Fig. 2. Localization of SM fusion in Sf9 cells during transient expression. The SM-fusion construct 33-GFP was transiently expressed in Sf9 cells, and a
representative Z image through the center of the nucleus is shown. Colocalization of 33-GFP with lamin (A), calreticulin (B), and calnexin (C) is shown. (D) 23-GFP
was transiently expressed in Sf9 cells, fixed, and prepared for electron microscopy. The cells were probed with antibody to GFP and gold-conjugated secondary
antibody; ER, ONM, and INM localization is noted. (E and F) Z sections showing localization of 33-GFP transiently expressed in Sf9 cells and colocalization with
lamin (row 1) and calnexin (row 2) under conditions of semi- (E) or full (F) permeabilization.
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plex (Fig. 4B, lanes 3 and 5), whereas they failed to precipitate
the cassette or a protein at the molecular weight of the cross-
linked complex from the negative control (Fig. 4B, lanes 4 and
6). The blots were reprobed with antibody to FP25K or E26, and
in each case, in addition to IgGs, one band was detected: that of
the free, nonbound protein (data not shown). For additional
confirmation, the SM cassette and cross-linked complex were
purified, separated by using SDSPAGE, and Western blotted.
T7 antibody detects both the SM cassette and cross-linked
product (Fig. 4B, lane 10), whereas -FP25K detected the
cross-linked complex and free FP25K (Fig. 4B, lane 9). We note
that after exposure to cross-linking reagent, antibodies to FP25K
Fig. 3. Localization of SM mutants. Clones from each group were transiently expressed in Sf9 cells, and a representative Z section is shown. ER was identified
by using antibody to calreticulin and DNA labeled with 4,6-diamidino-2-phenylindole, whereas the SM fusion was detected by GFP autofluorescence. If two
clones are represented within the same group, the results were visually indistinguishable.
Fig. 4. The SM sequence is proximal to FP25K and E26. (A) Sequence of the SM cassette. Placement of the unique lysines (*), position of the T7 epitope tag,
and C-terminal (His)6 are shown. (B) Sf9 cells were infected with the polhSM-cassette virus, cells were collected at 33 h after infection, and nuclei were purified
and exposed to BS3. 0, No cross-linker; X, addition of cross-linking reagent. The SM cassette and cross-linked adduct were detected by using antibody to T7 (lanes
1–8). Lanes 1 and 2 show total nuclear extract, whereas lanes 3–8 show product precipitated with antibodies: FP25K (lanes 3 and 4), E26 (lanes 5 and 6), and normal
rabbit serum (lanes 7 and 8). Disrupted nuclear extracts were treated with Talon beads to purify the SM cassette and cross-linked complex, and proteins were
separated by using SDSPAGE and Western blotted. The identity of the proteins was determined by using antibodies to FP25K (lane 9) or T7 epitope (lane 10).
(C) The SM cassette was translated in the presence of infected Sf9 cell microsomes (33 h after infection) and [35S]Met, and then treated with BS3. The proteins
were precipitated by using antibodies to T7, FP25K, E26, ODV-E25, p39, and polyhedrin (lanes 11–16, respectively) and separated by SDSPAGE, and protein was
detected by using incorporated [35S]Met.








and E26 precipitate the free SM cassette (Fig. 4B, lanes 3 and 5,
and 4C, lanes 12 and 13), whereas they cannot precipitate the SM
cassette in the absence of cross-linking reagent (Fig. 4B, lanes 4
and 6). Antibody precipitations were performed by using buffer
that should denature protein complexes; thus the ability of the
SM cassette to remain associated with either FP25K or E26
suggests the cross-linking reagent is doing something to help
maintain association of the noncovalently bound proteins in
these complexes. Non-cross-linked FP25K binds to the Talon
beads (Fig. 4B, lane 9); this interaction can be removed by using
8 M urea, whereas the binding of the cross-linked complex to
Talon or Ni remains (data not shown).
The SM cassette cross-linking with FP25K andor E26 could
be the result of a stable interaction occurring within the virion
or represent a trafficking intermediate. To discern which, the SM
cassette was translated in the presence of infected Sf9 cell
microsomes and then treated with BS3. Antibodies to T7, FP25K,
and E26 precipitated the free cassette and the cross-linked
complex (Fig. 4C, lanes 11–13). To confirm that the spatial
positioning of the SM and FP25K or E26 was not occurring
within intact virus, antibodies that would precipitate virus in
various stages of maturation were tested: p39, ODV-E25, and
polyhedrin (precipitate nucleocapsids, mature virus, and par-
tially occluded virus, respectively). None of the antibodies
precipitated the translated SM cassette or cross-linked complex
(Fig. 4C, lanes 14–16). Finally, when a truncated version of E66
(132 aa) was translated in vitro and treated with cross-linking
reagent, FP25K and E26 were precipitated with E66 antibody
(data not shown). We conclude from these experiments that (i)
the cross-linked complexes are not a result of protein interac-
tion(s) occurring within the assembled virion and (ii) are not a
result of interactions occurring within the lysine-free portion of
the fusion protein. Rather, FP25K andor E26 are spatially
positioned close to the lysines of the SM, while the protein
resides within the ER.
Fig. 5. Comparison of SM with resident INM proteins. (A complete description of this figure and associated references are available in supporting information.)
The TM and flanking sequence of the hydrophobic sequence most likely to influence INM localization are shown. TheG for membrane insertion was calculated
by using the White–Wimley (octanol interface) scale. The orientation is shown with placement of the positively charged amino acids on the cytoplasmic
nucleoplasmic face noted.
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Many Resident Proteins of the INM Contain an SM-Like Sequence.
There are significant similarities between trafficking of E66 and
SM-fusion proteins with resident INM proteins (for a review of
INM protein trafficking see ref. 12). Therefore, we asked
whether INM proteins contain features similar to the viral SM.
Because some INM proteins are polytopic, the comparison was
made with the TM sequence known to influence protein local-
ization (Fig. 5 and references shown in supporting information,
which is published on the PNAS web site). Most of the TM
sequences are similar in length, ranging from 17 to 19 aa. The
calculated G values for membrane insertion (kcalmol) have
values ranging from 10.45 (E66) to less favorable values such
as 3.03 (nurim). The length and calculated G values of these
proteins are similar to examples of resident ER proteins: ribo-
phorin I and II have TM sequences composed of 19 aa, with
G values of 7.13 and 6.87, respectively. The only charac-
teristic we can discern by using computer-assisted or manual
‘‘sequence gazing’’ is a lack of charged amino acids within the
hydrophobic sequences.
Because the spacing and orientation of the positively
charged amino acids f lanking the viral SM seem to be critical
for proper protein targeting, we questioned whether the TM
sequences of the INM proteins retained these features. The
comparison shows that for all the INM proteins with orienta-
tion that is known, the orientation and spacing to the charged
amino acids is similar to that of the SM: they are present on
the nucleoplasmic face and within 5–8 aa from the end of the
TM sequence. This is true even if the TM sequence has been
shown to play only a minimal role in INM targeting (LAP2,
emerin, MAN1, and POM121). Together, these observations
suggest that the most relevant TM domains for INM protein
trafficking of well characterized INM proteins share charac-
teristics of the viral SM sequence.
Discussion
The N-terminal 33 aa of E66 are sufficient to traffic fusion
proteins to the ODV envelope with an efficiency similar to
wild-type protein. If the associated charged amino acids are
maintained, this sequence can be shortened to 23 aa (1). We
show that in the absence of infection, this sequence is also
sufficient to promote protein accumulation at the INM (Fig. 2).
This sequence contains two features, a hydrophobic sequence
and associated charged amino acids oriented on the cytoplas-
micnucleoplasmic face. The mutational analysis showed that
the efficiency of protein accumulation at the INM was decreased
when placement to the positively charged lysines was altered
(Fig. 3).
If protein–protein interactions are important for viral SM-
fusion trafficking, such interactions should be at optimal levels
during viral infection. Thus, experiments were designed to
identify such interactions using infected cells and the lysines of
the SM as bait. Chemical cross-linking experiments resulted in
cross-linked complexes containing two viral proteins: FP25K
andor E26. Because FP25K has already been implicated in the
trafficking of E66 (7, 13), its identification here poses the
possibility that it directly interacts with E66. The function of
FP25K and E26 are undetermined; however, it has been
speculated that they interact with actin andor cytoplasmic
dynein (14).
The data in this article suggest that once inserted into the ER,
the SM fusion interacts with the viral proteins FP25K andor
E26 during trafficking to the nuclear envelope. The possibility
that E66 required other viral proteins for efficient passage from
the ER to the INM was first postulated when it was observed that
E66 accumulated in punctate regions associated with the ONM
and was not detected at the INM or to viral-induced membranes
within the nucleus when FP25K was deleted from the genome (7,
13). These results suggest that FP25K may affect passage of E66
from the ONM to the INM, potentially by facilitating trafficking
through the lateral channels of the nuclear pore.
In the absence of infection, SM-fusion proteins are present
within the ER; however, they also show a distinct rim at the INM.
This is surprising, because E66 or SM fusions do not contain
sequences that would predict binding to nucleoplasmic proteins
or DNA. Considering that mammalian resident INM proteins
also contain features similar to the viral SM, it is possible that
the SM-like sequences facilitate accumulation at the INM, and
this is independent of retention sequences. Thus, the SM-like
sequence may be sufficient to promote directional movement but
not immobilization at the INM.
It is known that cytoplasmic intraorganelle movement of
membrane proteins is highly regulated and includes protein–
protein and protein–lipid interactions. Although it is possible
that the continuous membranes of the ER, ONM, pore mem-
brane, and INM require a less elaborate mechanism of traffick-
ing, it is possible also that more than one mechanism exists for
ER-to-INM trafficking. The diffusion-retention model (12) may
describe the essential features for some resident INM proteins;
however, proteins containing larger cytoplasmic domains (e.g.,
Nesprin-1; Fig. 5) may require other factors for optimal passage
across the nuclear pore lateral channels. We propose that the
viral protein E66 may be an example of such a protein. E66
exposes most of its mass at the cytoplasmic face; thus during
passage across the lateral channels, the exposed protein would be
at the upper limit of free passage [76 kDa (15)]. Considering
trafficking to the INM has been studied in detail for only a few
proteins, it remains to be determined whether trafficking for the
increasing complement of proteins that compose the INM will be
explained successfully by diffusion retention or whether multiple
pathways andor regulatory events function in this pathway.
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